JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fornai, F.
Right arrow Articles by Corsini, G. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fornai, F.
Right arrow Articles by Corsini, G. U.

Vol. 283, Issue 1, 100-107, 1997

Effects of Noradrenergic Lesions on MPTP/MPP+ Kinetics and MPTP-Induced Nigrostriatal Dopamine Depletions

Francesco Fornai , Maria Grazia Alessandrì, Maria Tilde Torracca, Lucia Bassi and Giovanni Umberto Corsini

Institute of Pharmacology (F.F., M.T.T., L.B., G.U.C.) and IRCCS Stella Maris-INPE (F.F., M.G.A.), University of Pisa, Italy

Norepinephrine (NE) depletion caused by damage to locus ceruleus neurons was shown to worsen experimental Parkinsonism induced by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys and in rodents. However, it is not clear whether the lesion to the NE system enhances neurotoxicity in the nigrostriatal dopaminergic (DA) pathway and/or impairs the recovery of DA neurons once the neurotoxic insult is generated. In this study, we provide evidence that the lesion of NE terminals, induced by the selective neurotoxin N-(-2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4; 50 mg/kg), must occur before MPTP (30 mg/kg) administration in order to enhance MPTP toxicity. As a second step, we evaluated the acute effects of MPTP on the nigrostriatal DA pathway in NE-lesioned animals compared with intact animals. We observed a more marked acute DA depletion, persisting at 12 h, in DSP-4 + MPTP-treated mice compared with MPTP-injected controls. These findings, combined with the lack of an MPTP enhancement when NE depletion was induced 12 h after MPTP administration, suggest that in NE-depleted animals, a more pronounced acute neuronal sensitivity to MPTP occurs. In line with the hypothesis of an acute protective effect by NE axons, we evaluated whether the enhancement of MPTP toxicity in NE-lesioned animals is achieved through alterations to the kinetics of MPTP and its metabolite. Our findings indicate that despite the pivotal role of NE terminals in taking up and storing 1-methyl-4-phenylpyridinium (MPP+), MPTP enhancement does not depend on modifications in the striatal kinetics of MPTP/MPP+ measured at seven different time intervals after MPTP administration.

Copyright © by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
K. S. Rommelfanger, G. L. Edwards, K. G. Freeman, L. C. Liles, G. W. Miller, and D. Weinshenker
Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice
PNAS, August 21, 2007; 104(34): 13804 - 13809.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Smeyne, J. Boyd, K. Raviie Shepherd, Y. Jiao, B. B. Pond, M. Hatler, R. Wolf, C. Henderson, and R. J. Smeyne
GST{pi} expression mediates dopaminergic neuron sensitivity in experimental parkinsonism
PNAS, February 6, 2007; 104(6): 1977 - 1982.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
J. Tong, O. Hornykiewicz, and S. J. Kish
Inverse Relationship Between Brain Noradrenaline Level and Dopamine Loss in Parkinson Disease: A Possible Neuroprotective Role for Noradrenaline
Arch Neurol, December 1, 2006; 63(12): 1724 - 1728.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
G. Battaglia, C. L. Busceti, G. Molinaro, F. Biagioni, A. Traficante, F. Nicoletti, and V. Bruno
Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
J. Neurosci., July 5, 2006; 26(27): 7222 - 7229.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. Fornai, O. M. Schluter, P. Lenzi, M. Gesi, R. Ruffoli, M. Ferrucci, G. Lazzeri, C. L. Busceti, F. Pontarelli, G. Battaglia, et al.
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and {alpha}-synuclein
PNAS, March 1, 2005; 102(9): 3413 - 3418.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
G. Battaglia, C. L. Busceti, G. Molinaro, F. Biagioni, M. Storto, F. Fornai, F. Nicoletti, and V. Bruno
Endogenous Activation of mGlu5 Metabotropic Glutamate Receptors Contributes to the Development of Nigro-Striatal Damage Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in Mice
J. Neurosci., January 28, 2004; 24(4): 828 - 835.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M.-L. Wong, M. A. Kling, P. J. Munson, S. Listwak, J. Licinio, P. Prolo, B. Karp, I. E. McCutcheon, T. D. Geracioti Jr., M. D. DeBellis, et al.
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone
PNAS, January 4, 2000; 97(1): 325 - 330.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.